NLAB Saga®

NLAB Saga® is a perfectly spherical, fully porous silica with superior mechanical stability and exceptional
chemical stability at high and low pH, making it an
optimum choice for large scale purification of peptides.


Nanologica is a Swedish nanotechnology company, world-leading in the development of
nanoporous silica particles for purification by chromatography.

We aim to make a positive impact to the world by leveraging our expertise for the betterment of mankind.
Our mission is to increase the availability of cost-effective drugs, enabling more patients around the world access to vital treatments for diabetes and obesity.

Chromatography is a widely used technique for separating components in a mixture. We are active mainly in preparative chromatography, which is used by pharmaceutical manufacturers for purification of drugs, e.g. insulin, during production.  

Through a proprietary production method, we create silica-based products that can purify more effectively and that last longer. This can
reduce production costs and increase productivity for pharmaceutical manufacturers. 


Nanologica receives order for purification media, MSEK 3.6 value

NANOLOGICA RECEIVES ORDER OF PURIFICATION MEDIA WORTH APPROX. MSEK 3.6 Nanologica expands its product portfolio of purification medias for preparative chromatography and has received a trial order worth approximately MSEK 3.6 from a customer in Asia. Product development of this purification media, NLAB Siv™, has been conducted together with a customer who has a number

Read more »

Listen to our team talk about Nlab Saga®

Play Video about Katarina Alenäs – SVP Chromatography

Interview with Katarina Alenäs,
SVP Chromatography

Play Video

Interview with Olga Krivosheeva, Ph.D.
Application Project Manager 

Play Video

Interview with Chunfang Zhou, Ph.D.
Sales Manager China

Nanologica is a public company listed for trade on Nasdaq Stockholm Main Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.

Presentation of Nanologica

For more videos presentations of the company and of interim reports, please refer to Investor Relations.

Company presentation made by CEO Andreas Bhagwani in June, 2023.

Investor Pitch Deck September 2023.

Please contact us at for more information.